Parkes Weber syndrome is a rare congenital vascular anomaly, related to the RAS p21 protein activator 1 (RASA1) gene. It is characterized by capillary cutaneous malforma tions, bony and soft tissue hyperplasia, and multiple arteriovenous fistulas throughout the affected upper or lower extremity. These arteriovenous fistulas can be associated with lifethreatening complications such as bleeding, thrombosis, and high output heart failure. In this report, we present a neonate who had a disproportionately hypertrophied left upper limb with portwine stain, dystrophy of the left humerus, and hypertrophy of the left clavicle on Xray, and arteriovenous malformation and massive dilatation of the left subclavian artery on magnetic resonance angiography. Exome sequencing analysis revealed a novel heterozygous splicing mutation (c.1776+2T>A) in the RASA1 gene. To the best of our knowledge, this report is the first case of RASA1related Parkes Weber syndrome in Korea. . Capillary malformation (CM) is a slowflow vascular malformation that forms on the skin as a pink to red macular lesion, otherwise known as a portwine stain 2) . If this portwine stain is accompanied by hypertrophy of the affected limb, the differential diagnoses to be considered include PWS, KlippelTrenaunay syndrome, and Proteus syndrome 3, 4) . CMAVM is a rare condition of atypical CMs associated with fastflow AVMs and multiple arteriovenous fistulas (AVFs) anywhere in the body 4, 5) . Among these CM AVMs, PWS includes capillary cutaneous malformation, limb hypertrophy, and multiple AVFs of the affected extremity. These AVFs can lead to abnormal bleeding, thrombosis, and heart failure 6, 7) . Some cases of PWS and CMAVMs have the same genetic abnormality due to mutations in the RAS p21 protein activator 1 (RASA1) gene, which affects the development of the vascular system 8, 9) . We report here, a case of PWS with the identification of a novel RASA1 splicing mutation. 
INTRODUCTION
Parkes Weber syndrome (PWS) is a rare congenital vascular anomaly, comprising of capillary, venous, lymphatic, and arteriovenous malformations (AVMs), characterized by hypertrophy of the affected extremity 1) . Capillary malformation (CM) is a slowflow vascular malformation that forms on the skin as a pink to red macular lesion, otherwise known as a portwine stain 2) . If this portwine stain is accompanied by hypertrophy of the affected limb, the differential diagnoses to be considered include PWS, KlippelTrenaunay syndrome, and Proteus syndrome 3, 4) . CMAVM is a rare condition of atypical CMs associated with fastflow AVMs and multiple arteriovenous fistulas (AVFs) anywhere in the body 4, 5) . Among these CM AVMs, PWS includes capillary cutaneous malformation, limb hypertrophy, and multiple AVFs of the affected extremity. These AVFs can lead to abnormal bleeding, thrombosis, and heart failure 6, 7) . Some cases of PWS and CMAVMs have the same genetic abnormality due to mutations in the RAS p21 protein activator 1 (RASA1) gene, which affects the development of the vascular system 8, 9) . We report here, a case of PWS with the identification of a novel RASA1 splicing mutation. . Its exact prevalence is unknown, but approximately 50 patients including three neonates have been reported until 2015 10, 11) . CM is the most common vascular anomaly, which is present at birth and found in 0.3% of the affected infants 2) . It comprises of increased and enlarged capillaries with increased blood flow near the skin, and appears as a pink to red macular lesion, often referred to as a portwine stain 6) . Unlike the capillary hemangiomas, skin lesions of CM tend to progress with time 4) . CMAVM is a rare complex vascular disorder, first described by Eerola et al. . This RASA1 gene is located on chromosome 5 at the position 14.3 and codes for p120RasGAP, which acts as a negative regulator of RET signaling and affects the Gprotein signaling TC21 regulation pathway. The p120RasGAP has an effect on cell growth, differentiation, and proliferation 16) . Mutations of the RASA1 gene affect CMAVM and lead to manifestations of PWS, but it is unclear how these mutations affect variable phenotypes 5, 8) . According to the National complications such as heart failure, venous ulceration, and aneurysm occur 7, 11, 13) . Recently, sirolimus, a mammalian target of rapamycin (mTOR) inhibitor used for venous and lymphatic malformation, has been tried but its effect has not been proven yet 17) .
In the present case, we identified a novel RASA1 heterozygous splicing mutation in a patient with PWS presenting a severely hypertrophied left upper limb with portwine stain and AVM.
To our knowledge, this is the first case of RASA1related PWS in Korea.
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by atypical multifocal CMs, which are associated with fastflow
AVFs. AVMs and AVFs involve an abnormal connection between arteries and veins that affect blood circulation 6) . They can occur anywhere in the body including cutaneous, subcutaneous, intra muscular, intraosseous, and cerebral regions 3, 4) . The clini cal symptoms depend on the location and extent of AVMs.
These AVFs can lead to severe complications, such as abnormal bleeding, thrombosis, and heart failure 6, 11) . Such highflow AVMs tend to appear during infancy, but some occur later in childhood 3, 4) . Proteus syndrome is caused by mutations in the AKT serine/ threonine kinase 1 (AKT1) gene 13) . PWS is a kind of CMAVM, comprising limb hypertrophy with cutaneous capillary stain and multiple AVFs of the extremity. These AVFs can cause local warmth with thrill of the affected limb. In addition, varicose veins and lymphedema may coexist due to venous and lymphatic mal formations 4) . In our case, the patient had a pink to red macular lesion and disproportionately severe hypertrophy of the left extremity and local warmth with bruit was felt in the affected limb since birth.
The diagnosis of PWS is usually based on the clinical features described above. Diagnostic imaging is necessary to assess the location and extent of AVMs. Initial evaluation can be performed with Dopplerultrasound for distinguishing fastflow AVM from the slowflow vascular malformation 14) . Further anatomic details are obtained using MRI and MRA, which can reveal musculoskeletal abnormalities, as well as vascular malformations including engorged arteries, veins, capillaries, and flow voids 12, 15) .
